Standout Papers

Targeting p53–MDM2 interaction by small-molecule inhibitors: learning from MDM2 inhibitors in clinical trials 2022 2026 2023 2024119
  1. Targeting p53–MDM2 interaction by small-molecule inhibitors: learning from MDM2 inhibitors in clinical trials (2022)
    Haohao Zhu, Hui Gao et al. Journal of Hematology & Oncology

Immediate Impact

1 from Science/Nature 63 standout
Sub-graph 1 of 21

Citing Papers

MDM2 Inhibitors for Cancer Therapy: The Past, Present, and Future
2024 Standout
Understanding the complexity of p53 in a new era of tumor suppression
2024 Standout
1 intermediate paper

Works of Zhenhe Zhou being referenced

Targeting p53–MDM2 interaction by small-molecule inhibitors: learning from MDM2 inhibitors in clinical trials
2022 Standout

Author Peers

Author Last Decade Papers Cites
Zhenhe Zhou 285 307 166 302 77 1.1k
Qin Zhang 378 314 242 54 85 1.4k
Katherine E. Miller 241 75 338 162 86 1.1k
Yadan Li 309 384 304 79 87 1.3k
Tomoko Nishimura 106 322 50 105 76 1.2k
Sungwon Roh 147 117 75 256 66 1.2k
Wataru Ukai 59 417 32 159 49 1.3k
Stephen H. Chen 82 154 96 147 43 1.4k
Wai S. Tse 173 104 255 107 42 1.2k
Giacomo Mancini 227 84 201 169 50 1.3k
Xufeng Liu 310 64 412 110 115 1.3k

All Works

Loading papers...

Rankless by CCL
2026